Photo: investingnote.com

On Wednesday (19 Feb) morning, Singapore stocks rose after the Budget 2020 announcement the previous day. The losses of Tuesday have been reversed with the budget announcement which highlights the provision of S$5.6 billion to aid households, workers and firms to combat the Covid-19 outbreak.

The newest budget also maintains emphasis on the future, such as economic transformation as well as climate change.

The benchmark Straits Times Index (STI) opened at 3,199.8, which is 3.17 points or 0.1 per cent higher. The STI was trading up at 3,219.47, which is 22.84 points or 0.7 per cent higher.

On Tuesday (18 Feb), with investors focusing on Apple’s warning about its revenue loss from the Covid-19 epidemic and economic slowdown, the STI plunged for a fourth day by 16.37 points or 0.5 per cent. This also includes the cancellation of flights by Singapore Airlines across its global network for the next three months due to the weakened demand as a result of the virus outbreak.

Wednesday’s most heavily traded volume were AEM Holdings which rose by S$0.05 or 2.3 per cent to S$2.22 at 9.02 am with one million shares traded as well as ESR-Reit which was flat S$0.53 with 1.6 million shares traded at 9.06 am.

The three banks, DBS, UOB and OCBC remained in the red. On Wednesday at 9.02 am, DBS dropped S$0.02 or 0.1 per cent to S$25.25, UOB dropped S$0.07 or 0.3 per cent to S$25.74 and OCBC dropped S$0.04 or 0.4 per cent to S$10.93. All three banks had closed lower on Tuesday.

The country’s largest telco, Singtel was unchanged on Wednesday morning at S$3.17. It fell 1.3 per cent to close at that value yesterday. Last Thursday (13 Feb), Singtel reported its Q3 earnings, following which its shares dropped 6 per cent.

In the early trading session, recovery could be seen in aviation stocks after extra measures were introduced in the budget such as rental waivers and property tax rebates for aviation and other sectors that were impacted by the Covid-19 outbreak.

Ground handler Sats saw its stocks rose S$0.03 or 0.7 per cent to S$4.51 whereas Singapore Airlines’ stocks rose S$0.03 or 0.4 per cent to S$8.54.

As for Great Eastern, its stock rose S$0.16 or 0.7 per cent to S$21.98. Also, OCBC’s insurance arm announced on Wednesday morining its net profit of S$287 million for Q4, which is more than double the S$136.9 million last year.

On Tuesday, Wall Street closed lower due to the worries over the Covid-19 outbreak and the impact on Apple. Apple’s share price dropped 1.8 per cent to US$319 after it announced on Monday that March’s quarter revenue forecast will not be met, and global iPhone supplies will dwindle.

In Japan, Tokyo stocks opened higher on Wednesday as investors recalibrated their positions in the wake of fears regarding the effect of the outbreak.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Study by NTU ranks Singapore as second in terms of fare affordability out of 12 cities

Singapore ranked second in terms of fare affordability, across 12 major cities,…

人民之声林鼎:贪污调查局和选举局应成为独立机构

人民之声领袖林鼎律师昨日(26日)脸书直播提及,该党成员在走访白沙—榜鹅集选区时,发生一段插曲。 林鼎表示,当时他被告知,有该党成员和志愿者被警方调查,并短暂扣在一间小室,警方称当时他们正手握另一政党的照片。 林鼎解释,“是的,他确实是,我有一个非常热情的成员,当时他正握着各个人民行动党在国会上睡觉的照片。” 对此,林鼎提出质疑表示,这难道形成任何刑事犯罪吗?最终,该名成员也未获得任何的指控和起诉。 他也举例日前前进党成员被指违反社交距离,结果被记名一事,并与在阻断措施期间仍走访社区的人民行动党成员做比较。 曾《防假消息法》打击,冀公众重新思考 他也指出,从中就可得知其中的不公平象征,并提及《防假消息法》一般都用于针对如同他一样身份的在野党人员。 “因为我们批评政府和他们的政策,所以当部长不喜欢,他们可以用《防假消息法》对付你,而且会以更正通知暗示帖文含虚假消息。” 林鼎也揭露自身经历,他曾因质疑何晶薪水而被冠上“假消息”的指控,并以《防假消息法》要求更正。因此,他也希望公众能够重新思考“一切声音被压抑的国会”对日常生活会产生何种影响。 “你会意识到,为何选出直言不讳的人是非常重要的,今天在国会中有好些议员没发挥作用,可以发现他们在工作时打盹,也几乎不提出任何异议,所以你值得更好的。” 对此,观众也提问他对于国会中打盹的议员,他表示,国会如今已经是非常不活跃的国会,大多数都是成员提前提交,甚至会出现部长让其他人回答问题。林鼎强调国会是必须对人民负责,部长需要有能力处理意想不到的问题。 “如同前财政部长王瑞杰面对在野党的一个小问题,却花了无数时间在翻纸和要求休会,足以证明他们无法处理即时的问题。”…

直销“套路”鹿胎素有治癌疗效 卫生科学局证“绝无此事”

卫生科学局(HSA)点名警告保健直销公司力汇国际(Riway International),禁止该公司对消费者宣传旗下保健食品有治愈癌症的误导信息。 根据《海峡时报》报道,卫生科学局日前发现,力汇国际的最近主打产品Purtier鹿胎盘素(Purtier Placenta)在推销过程,宣称产品是以鹿胎素提炼,是一种干细胞治疗方案,透过摄入药丸便能达其治疗效果。 卫生科学局发言人对此表示,目前仍在调查中。 “对于提供误导信息的产品,一旦发现有任何违反法律的行为,我们将严格采取法律行动,厂商若被发现有夸大、过度宣传或谎报药效的行为,会有被检控之虞,一旦罪成,可能会面临最高两年的监禁或被罚款最高5000新元” 直销商宣称治疗严重疾病效果佳,出现误导信息 自2017年1月起,消费者协会已陆续收到6起有关产品的投诉案件,其中3三起案件以产品含误导信息向协会投诉。 《海峡时报》指出,直销商宣称许多身患癌症、哮喘或中风的严重疾病者在服用该产品后得到好转,而该公司的收入也因产品的好销量而从2009年300万美元营收增至2017年40亿美元营收,以此向消费者证明产品的良好药效。 卫生科学局强调,针对主打干细胞治疗方案的医疗产品,民众需特别谨慎,他表示,“截至目前仍未有有力的科学证据,证明活细胞治疗方案的有效性。” “与此同时,并无任何医学证明口服干细胞能够预防或治疗疾病的证据。基本上,当我们将干细胞服用后,胰脏内的酶素只会将干细胞破坏而已,无法产生任何疗效。” “未有科学证明”…

130 new cases of COVID-19 infection in S’pore; 127 locally transmitted cases, 75 linked to Jurong Fishery Port cluster and 5 belong to KTV cluster

As of Saturday noon (24 July), the Ministry of Health (MOH) has…